MICHELLE ALLISON: Open Payments
NPI 1578930574 · GAFFNEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 33 payments from 6 companies in 2025. Trend: 2023 $536 · 2024 $295 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $155 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, COBENFY, REXULTI, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR, HETLIOZ.
Industry payments across SC — which companies pay providers there.
